论文部分内容阅读
[目的]观察莫沙比利联合布拉氏酵母菌治疗小儿功能性再发性腹痛(RAP)的疗效。[方法]将68例RAP患儿随机分为治疗组和对照组各34例,治疗组用莫沙比利0.3mg/(kg.d),每天3次餐前口服,联合布拉氏酵母菌0.5g,每天2次餐后口服。对照组34例单纯口服莫沙比利(用法同上),4周一疗程。[结果]总有效率治疗组94.12%,对照组73.53%,2组比较差异有统计学意义(P<0.05)。[结论]莫沙比利联合布拉氏酵母菌治疗小儿RAP疗效显著,复发率低,方法简便易行,值得临床推广。
[Objective] To observe the curative effect of mosapride combined with bourgeois in the treatment of pediatric functional recurrent abdominal pain (RAP). [Methods] 68 children with RAP were randomly divided into treatment group and control group, 34 cases each. The treatment group was treated with mosapride 0.3mg / (kg.d), orally three times a day before meals, 0.5g, 2 times a day after oral administration. Control group of 34 patients simply oral mosapride (used above), 4 weeks treatment. [Results] The total effective rate was 94.12% in the treatment group and 73.53% in the control group, with significant difference between the two groups (P <0.05). [Conclusion] Mosapride and B. Saccharomyces are effective in treating RAP in children, and the relapse rate is low. The method is simple and easy to implement and worthy of clinical promotion.